Pfizer, Flagship return to obesity as part of latest additions to multibillion-dollar collaboration

Pfizer and Flagship Pioneering are continuing to fill in the blanks for their 10-program partnership, unveiling agreements with two more Flagship-founded biotechs to chase targets in obesity and lung cancer.